share_log

嘉必优(688089.SH):暂未涉及NMN相关技术和研发

cabio biotech(wuhan) (688089.SH): has not yet involved in NMN related technology and research

Gelonghui Finance ·  Nov 19, 2024 03:27

Jiabiyou (688089.SH) stated on the interactive platform on November 19th that the company uses synthetic biology as the underlying technology, cell factory as the preparation method, and sustainable biomanufacturing to provide high-quality nutrient products and innovative solutions for global nutrition and health customers. Currently, the main products include polyunsaturated fatty acids class ARAs, algae oil DHAs, terpenes beta-carotene, astaxanthin, saccharides SAs, and HMOs, which are widely used in the fields of infant formula milk powder, large health food, animal nutrition, personal care, and beauty, and based on the characteristics of synthetic biology underlying technology, expand to the fields of biomedicine, biomaterials, biotechnology, etc., temporarily not involved in NMN (nicotinamide mononucleotide) related technology and research and development.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment